1. Home
  2. SOUN vs ADMA Comparison

SOUN vs ADMA Comparison

Compare SOUN & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SoundHound AI Inc

SOUN

SoundHound AI Inc

HOLD

Current Price

$3.09

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

SELL

Current Price

$13.26

Market Cap

2.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SOUN
ADMA
Founded
2005
2004
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.5B
IPO Year
2021
2012

Fundamental Metrics

Financial Performance
Metric
SOUN
ADMA
Price
$3.09
$13.26
Analyst Decision
Strong Buy
Buy
Analyst Count
6
4
Target Price
$12.00
★ $18.00
AVG Volume (30 Days)
★ 14.7M
3.8M
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 73.08
N/A
EPS
N/A
★ 0.57
Revenue
N/A
★ $42,219,783.00
Revenue This Year
$60.18
$4.83
Revenue Next Year
$43.27
$14.54
P/E Ratio
★ N/A
$23.66
Revenue Growth
N/A
★ 43.85
52 Week Low
$3.20
$7.21
52 Week High
$13.19
$20.46

Technical Indicators

Market Signals
Indicator
SOUN
ADMA
Relative Strength Index (RSI) 17.11 64.11
Support Level N/A $7.71
Resistance Level $8.97 $13.77
Average True Range (ATR) 0.24 0.72
MACD -0.05 0.12
Stochastic Oscillator 5.36 78.53

Price Performance

Historical Comparison
SOUN
ADMA

About SOUN SoundHound AI Inc

SoundHound AI Inc is an innovator of conversational intelligence, offering an independent Voice AI platform that enables businesses across industries to deliver high-quality conversational experiences to customers. The company's voice AI delivers speed and accuracy in numerous languages to product creators and service providers across retail, financial services, healthcare, automotive, smart devices, and restaurants via groundbreaking AI-driven products like Smart Answering, Smart Ordering, Dynamic Drive-Thru, and Amelia AI Agents.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: